SCHEMBL14898342

SCHEMBL14898342

COC(=O)c1cccc(-c2cc(F)cc(OC)c2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 3/20 0.54
PLAU P00749 4/20 0.50
PLAT P00750 2/20 0.50
CA12 O43570 2/20 0.50
CA9 Q16790 2/20 0.50
MRGPRX4 Q96LA9 1/20 0.50
PLG P00747 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
NEK1 Q96PY6 1/20 0.50
GRM5 P41594 1/20 0.50
CYP1A1 P04798 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2E1 P05181 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C8 P10632 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2A6 P11509 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP4B1 P13584 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8440880 0.90 CYP1A1 (0.61) ERN1PLAUPLATCA12CA9
SCHEMBL8439910 0.90 ERN1 (0.60) ERN1PLAUCA12CA9MRGPRX4
SCHEMBL14784175 0.89 NPC1 (0.52) ERN1MRGPRX4NEK1CYP1A1CYP1A2
SCHEMBL14879920 0.87 RXRA (0.54) ERN1MRGPRX4CYP1A1CYP1A2CYP2E1
SCHEMBL22633962 0.87 MRGPRX4 (0.52) ERN1PLAUCA12CA9MRGPRX4
SCHEMBL7829981 0.85 ERN1 (0.58) ERN1PLAUCA12CA9MRGPRX4
SCHEMBL30790370 0.85 ERN1 (0.58) ERN1PLAUCA12CA9MRGPRX4
SCHEMBL6432447 0.85 NEK1 (0.63) ERN1PLAUPLATCA12CA9
SCHEMBL14880009 0.84 ERN1 (0.59) ERN1PLAUCA12CA9MRGPRX4
SCHEMBL14881384 0.83 CA12 (0.49) ERN1PLAUPLATCA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11970448-B2 Monomers capable of dimerizing in an aqueous solution, and methods of using same CORNELL UNIVERSITY (US) 2024-04-30 US disclosed
US-20200354319-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME UNIV CORNELL (US) 2020-11-12 US disclosed
US-20140194383-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME CORNELL UNIVERSITY (US) 2014-07-10 US disclosed
US-20140194383-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME CORNELL UNIVERSITY (US) 2014-07-10 US disclosed
WO-2013058824-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME CORNELL UNIVERSITY (US) 2013-04-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11970448-B2 Monomers capable of dimerizing in an aqueous solution, and methods of using same CALCOCO2, MDN1, MBNL1 ERN1 1720/4885PLAU 840/4885PLAT 3239/4885
US-20200354319-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME CALCOCO2, MDN1, MBNL1 ERN1 1720/4885PLAU 840/4885PLAT 3239/4885
US-20140194383-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME CALCOCO2, MDN1, MBNL1 ERN1 1720/4885PLAU 840/4885PLAT 3239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.